Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Among kidney transplant recipients who had contracted COVID-19, rates of acute rejection were low ...

Study covers COVID-19 epidemic waves and virus variants. Some maintenance immunosuppressive drugs to prevent graft rejection may increase the risk for COVID-19 hospitalization among solid organ ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. During the study period, 11.4% of solid organ transplant ...

In a recent study published in the PLoS ONE journal, researchers assessed the impact of baricitinib, netakimab, and tocilizumab against coronavirus disease 2019 (COVID-19). Study: Tocilizumab, ...

Most patients with RA are taking multiple medications, which must be managed during the perioperative period. Do patients who receive treatment with long-term immunosuppressive medications have worse ...

Older age was also a risk factor for hospitalization and death in patients with myeloproliferative neoplasms (MPN) who contract COVID-19, the investigators found. People with myeloproliferative ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Immunosuppressive drugs for the treatment of atopic ...

About The Study: The findings of this study suggest that maintenance immunosuppressive drugs are associated with an increased risk of COVID-19 hospitalization in solid organ transplant recipients.

Patients with atopic dermatitis, psoriasis, or vitiligo who use immunosuppressants or were vaccinated against COVID-19 are not at an increased risk of developing COVID-19. Progressive disease activity ...

Yearly Covid-19 Booster Recommendations in Canada, Europe, and Australia. Although the rapid development of multiple Covid-19 vaccines in 2020 represents a major scientific, medical, and regulatory ...